Advanced search
Publication Cover
Cancer Biology & Therapy Volume 25, 2024 - Issue 1
Submit an article Journal homepage
1,242
Views
0
CrossRef citations to date
0
Altmetric
Report

Significant response to pembrolizumab plus lenvatinib in Epstein–Barr-virus-associated intrahepatic cholangiocarcinoma: a case report

Lisha LiCancer Center, Institute of Radiation Oncology, Hubei Key Laboratory of Precision Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaView further author information
,
Dandan YuCancer Center, Institute of Radiation Oncology, Hubei Key Laboratory of Precision Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaView further author information
,
Jinru YangCancer Center, Institute of Radiation Oncology, Hubei Key Laboratory of Precision Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaView further author information
,
Fangyuan ZhangCancer Center, Institute of Radiation Oncology, Hubei Key Laboratory of Precision Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaView further author information
,
Dejun ZhangCancer Center, Institute of Radiation Oncology, Hubei Key Laboratory of Precision Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaView further author information
,
Zhenyu LinCancer Center, Institute of Radiation Oncology, Hubei Key Laboratory of Precision Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaView further author information
,
Menglan ZhaiCancer Center, Institute of Radiation Oncology, Hubei Key Laboratory of Precision Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaView further author information
,
Jing WangCancer Center, Institute of Radiation Oncology, Hubei Key Laboratory of Precision Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaView further author information
,
Tao ZhangCancer Center, Institute of Radiation Oncology, Hubei Key Laboratory of Precision Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaCorrespondence[email protected]
View further author information
&
Lei ZhaoCancer Center, Institute of Radiation Oncology, Hubei Key Laboratory of Precision Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2876-4347View further author information
ORCID Icon show all
Article: 2338644 | Received 16 Oct 2022, Accepted 31 Mar 2024, Published online: 22 Apr 2024

Figures & data

Figure 1. The change of enhanced computed tomography of liver.

Figure 1. The change of enhanced computed tomography of liver.

Figure 2. Histological pictures of liver biopsy.

Figure 2. Histological pictures of liver biopsy.

Figure 3. The change of alpha-fetoprotein (AFP).

Figure 3. The change of alpha-fetoprotein (AFP).

Figure 4. The timeline summarizing the main events of this case report.

Figure 4. The timeline summarizing the main events of this case report.

Data availability statement

All the data regarding the findings are available within the manuscript.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.